Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-05-02

Clinical Trial Update: Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Kidney Cancer Undergoing Cryosurgery [EARLY_Phase 1]

View source ↗

Summary

A clinical trial evaluating contrast-enhanced ultrasound to predict treatment response in renal cell carcinoma patients undergoing cryosurgery has been withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Renal Cell Carcinoma | EARLY_Phase 1 | Status: WITHDRAWN